Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica. Steinman L, Zamvil SS Ann Neurol. 2012 Mar; 71(3):287-8. PMID: 22451198. Abstract CommentRecommendBookmarkWatch